Affiliation:
1. MetroHealth Medical System Cleveland Ohio USA
2. Case Western University Cleveland Ohio USA
Abstract
AbstractCOVID‐19 infection has been a significant contributor to global morbidity and mortality, especially among those patients with chronic diseases. The Centers for Disease Control and Prevention have classified sickle cell disease (SCD) as a condition that increases the risk of severe illness from COVID‐19 infection.A retrospective study was conducted using the TRiNetX health research network database to identify SCA patients ( HbSS, Sbeta‐thalassemia zero) who had SARS‐CoV‐2 infection over 2 years; these were compared with similar patients who did not have the infection in terms of demographics, pain control, and laboratory parametersCOVID‐19 illness impacts [ain crises and ACS, and prior vaccination against influenza and COVID‐19 may represent a protective factor for developing pain crises.
Reference22 articles.
1. Inflammation in COVID‐19: from pathogenesis to treatment;Wong RSY;Int J Clin Exp Pathol,2021
2. The COVID-19 Pandemic and the $16 Trillion Virus
3. KarpmanM ZuckermanS GonzalezD KenneyGM.The COVID‐19 pandemic is straining families’ abilities to afford basic needs [Internet].2020. [cited 2023 Aug 8].https://www.urban.org/research/publication/covid-19-pandemic-straining-families-abilities-afford-basic-needs#:~:text=As%20families%20cope%20with%20new during%20the%20last%2030%20days
4. Characteristics of Hospitalized COVID-19 Patients Discharged and Experiencing Same-Hospital Readmission — United States, March–August 2020